AzTrials
AzTrials

Large Renal StoneNCT06394219

A Comparative Study Between Anterior and Posterior Pyelotomy in Transperitoneal Laparoscopic Pyelolithotomy

A study testing traditional transperitoneal laparoscopic pyelolithotomy and modified transperitoneal laparoscopic pyelolithotomy in people with Large Renal Stone, run by Damascus University at 1 site in Syria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Large renal pelvic stones are frequently managed with percutaneous nephrolithotomy (PCNL) but laparoscopic pyelolithotomy (LPL) can be an alternative procedure when performed by skilled surgeons to achieve excellent outcomes in terms of stone free status, operative time, postoperative kidney function, hospitalization… Read more about this study

Who is it for?
Ages 15 to 65 years
Conditions the study is for
Large Renal Stone
What is being tested?
traditional transperitoneal laparoscopic pyelolithotomy and modified transperitoneal laparoscopic pyelolithotomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteSyria
Study dates
1 Jan 2022to 1 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 65 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients with large renal pelvic stone > 2 cm .
  • failure of minimally invasive approaches such as PCNL or ESWL
  • stones that were neither amenable to ESWL nor were ideally suitable for PCNL
  • Patient's preference for a quick one-stage procedure.
  • Negative urine culture

Who cannot join

  • Patients refusing study participation.
  • Contraindication to general anesthesia.
  • Contraindication to laparoscopic surgery.
  • Patients with an intrarenal pelvis.
  • Previous surgical on the same kidney.
  • Associated anatomical deformity.

Trial locations and contacts

1 site in 1 country.

Syria1 site
  • Damascus University

    Damascus

Other trials in Syria

About this study

Official title: Transperitoneal Laparoscopic Pyelolithotomy: Is the Posterior Pyelotomy Better Than the Anterior? (A Randomized Controlled Clinical Trial)

Large renal pelvic stones are frequently managed with percutaneous nephrolithotomy (PCNL) but laparoscopic pyelolithotomy (LPL) can be an alternative procedure when performed by skilled surgeons to achieve excellent outcomes in terms of stone free status, operative time, postoperative kidney function, hospitalization duration, and complications.

there are two methods for LPL surgery : Transperitoneal (TLP) and Retroperitoneal (RLP).

Read more

RLP associated with shorter mean time for oral intake, and mean hospital stay after surgery.

The surgical exposure in the transperitoneal route for LP is familiar to the majority of surgeons. Also, a much larger working space is available and there are various established anatomical landmarks for performing the surgery effectively. This study introduces a modified technique that creates application of posterior pyelotomy in TLP to achieve the advantages of RLP

Read the detailed description

This is a randomized controlled clinical trial that aims to collect a sample within two years from the date of approval of the Scientific Research Council at Damascus University.

The study will focus on a group of patients who will undergo a transperitoneal laparoscopic pyelolithotomy surgery.

The patients will be randomly divided into two groups. The first group will undergo a traditional transperitoneal laparoscopic pyelolithotomy, which involves application of anterior pyelotomy.

The second group will receive a modified transperitoneal laparoscopic pyelolithotomy, which involves application of posterior pyelotomy.

The data will be compared between the two groups in terms of the mean duration of surgery ,mean time for oral intake ,and mean hospital stay

Being tested
traditional transperitoneal laparoscopic pyelolithotomy, modified transperitoneal laparoscopic pyelolithotomy
Keywords
Pyelotomy, Laparoscopic Pyelolithotomy,, pelvic stone, kidney stone
Medical subject headings
Kidney Calculi

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • traditional transperitoneal laparoscopic pyelolithotomyProcedure or surgery

    Also called TLP

    Performing anterior Pyelotomy.

  • modified transperitoneal laparoscopic pyelolithotomyProcedure or surgery

    Performing posterior pyelotomy

Study groups in NCT06394219
Study groupRoleWhat they receive
Anterior PyelotomyExperimentalTraditional transperitoneal laparoscopic pyelolithotomy: Patients who were randomized to receive classic transperitoneal laparoscopic pyelolithotomy
Receives: Procedure: traditional transperitoneal laparoscopic pyelolithotomy
Posterior PyelotomyExperimentalModified transperitoneal laparoscopic pyelolithotomy: Patients who were randomized to receive modified transperitoneal laparoscopic pyelolithotomy by applying posterior pyelotomy.
Receives: Procedure: modified transperitoneal laparoscopic pyelolithotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Operative time

    the duration of the surgical procedure. It is measured by minutes, and calculated from establishing the pneumoperitoneum until the surgery is completed by suturing the skin.

    It will be measured in the outcome by the mean

    Measured: at the end of surgery in the operating room

  2. Days for oral intake

    the number of days to start introducing oral fluids and food after surgery with good acceptance, and without vomiting or flatulence.

    It will be measured in the outcome by the mean

    Measured: Up to one week after surgery

  3. Days of hospital stay

    the number of days the patient stayed in the hospital after surgery. It will be measured in the outcome by the mean

    Measured: up to ten days after surgery

  4. Postoperative urine leak

    considered to be present when the drain contained >30 cc of urine the morning after surgery.

    It is measured by answering the question: Is there any urinary leakage, yes or no? It will be measured in the outcome by the ratio

    Measured: up to three days after surgery

  5. stone-free status

    postoperative radiological imaging demonstrating evidence of residual stones It will be measured in the Outcome by the ratio

    Measured: Up to one week after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 May 2024
  2. Study start1 Jan 2022
  3. Primary completion1 Jan 2024
  4. Study completion1 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06394219
Sponsor's protocol ID
Posterior Pyelotomy
Status last verified
Apr 2024
First submitted
23 Apr 2024
Last updated
1 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Soltani MH, Hossein Kashi A, Farshid S, Mantegy SJ, Valizadeh R. Transperitoneal Laparoscopic Pyelolithotomy versus Percutaneous Nephrolithotomy for Treating the Patients with Staghorn Kidney Stones: A Randomized Clinical Trial. Urol J. 2021 Dec 20;19(1):28-33. doi: 10.22037/uj.v18i.6831.

    PubMed 34927230
  • Bai Y, Tang Y, Deng L, Wang X, Yang Y, Wang J, Han P. Management of large renal stones: laparoscopic pyelolithotomy versus percutaneous nephrolithotomy. BMC Urol. 2017 Aug 31;17(1):75. doi: 10.1186/s12894-017-0266-7.

    PubMed 28859655
  • Al-Hunayan A, Abdulhalim H, El-Bakry E, Hassabo M, Kehinde EO. Laparoscopic pyelolithotomy: is the retroperitoneal route a better approach? Int J Urol. 2009 Feb;16(2):181-6. doi: 10.1111/j.1442-2042.2008.02210.x. Epub 2008 Dec 2.

    PubMed 19183229
  • Gaur DD, Agarwal DK, Purohit KC, Darshane AS. Retroperitoneal laparoscopic pyelolithotomy. J Urol. 1994 Apr;151(4):927-9. doi: 10.1016/s0022-5347(17)35124-8.

    PubMed 8126827
  • Radfar MH, Dadpour M, Simforoosh N, Basiri A, Nouralizadeh A, Shakiba B, Valipour R, Zare A. Laparoscopic pyelolithotomy in patients with previous ipsilateral renal stone surgery. Urologia. 2021 Feb;88(1):41-45. doi: 10.1177/0391560319890993. Epub 2019 Dec 23.

    PubMed 31868562
  • Wang X, Li S, Liu T, Guo Y, Yang Z. Laparoscopic pyelolithotomy compared to percutaneous nephrolithotomy as surgical management for large renal pelvic calculi: a meta-analysis. J Urol. 2013 Sep;190(3):888-93. doi: 10.1016/j.juro.2013.02.092. Epub 2013 Feb 27.

    PubMed 23454154

Questions about this trial

What is this clinical trial studying?

A study testing traditional transperitoneal laparoscopic pyelolithotomy and modified transperitoneal laparoscopic pyelolithotomy in people with Large Renal Stone, run by Damascus University at 1 site in Syria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Syria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Operative time (time frame: at the end of surgery in the operating room). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06394219, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in